A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults

Clinical trial NCT05952596 · UNKNOWN

Trial details

NCT number: NCT05952596
Sponsor: LG Chem
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Poliomyelitis Hepatitis B Haemophilus Influenzae Type b Infection

Start date: 2023-07-17
Primary completion: 2023-10-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.